Particle Therapy 2017

Challenges for new centers

• Increase in number of centres – Historical niche will not fill to full capacity

– Common cancer sites will have to be treated • Superior beam but – level-I clinical evidence is lacking

– Non-randomized comparaBve evidence is scarce – How choosing candidate cancers? – How dealing with cost and reimbursement

• This course: overview of clinical data with emphasis on comparaBve assessments